Smart science to improve lives™
Open search Basket 0 View basket
Blue and green washed image of LNP

George Dakwar, PhD

George Dakwar, PhD, Director Formulation Platform, CureVacGeorge Dakwar holds a PhD degree in drug delivery and nanomedicines since 2016 and is currently leading discovery formulation activities within CureVac (Tubingen, Germany). 

During his career, he has focused on the delivery of multiple RNA modalities (e.g., siRNA, mRNA, saRNA) and worked in different industrial functions including discovery and CMC development of lipid nanoparticles (LNPs).

Before joining CureVac, he served as an Associate Director at VaxEquity (Cambridge, UK) and a Senior Scientist Drug Product Development at eTheRNA Immunotherapies (Ghent, Belgium).